stocktrader

US stock index futures edged higher on Tuesday as investors weighed tentative signs of de-escalation between Washington and Tehran against a macro backdrop that remains uneasy. The mood turned more measured, as Washington moved to enforce a maritime blockade targeting Iran-linked traffic, while oil prices retreated from earlier highs on cautious optimism. Nearly two dozen… Continue reading Dow futures surge 100 points: 5 things to know before market opens

Even as global markets grapple with volatility triggered by the Iran war and sharp swings in oil prices, a growing number of brokerages and asset managers are turning constructive on US equities. Analysts point to resilient corporate earnings, improving valuations after recent corrections and the outsized role of technology companies in driving global profit growth… Continue reading Citi, BlackRock upgrade US equities on strong earnings, easing war risks

Swiss fragrance and flavour maker Givaudan reported stronger-than-expected first-quarter sales growth, supported by robust demand in its fragrance and consumer products segment. The company said its LFL sales rose 2.8% in the quarter. This excludes the impact of currency fluctuations, acquisitions, and disposals. This figure came in above a company-compiled consensus forecast of 1.9%. Analysts… Continue reading Givaudan beats sales estimates as fragrance demand lifts shares

BP is heading into its first-quarter results with an unusually strong message on earnings, but also with a less comfortable one on the balance sheet. The oil major said on Tuesday that its oil trading business is expected to deliver “exceptional” results in the first quarter. The forecasts are helped by the violent swings that… Continue reading What’s behind BP’s exceptional Q1 forecast, and debt surge with it?

Novo Nordisk on Tuesday announced a partnership with OpenAI to deploy artificial intelligence across its business, spanning drug discovery, manufacturing and commercial operations, as the Danish drugmaker looks to sharpen its competitive edge in the fast-growing obesity drug market. The company said the collaboration would leverage OpenAI’s technology to analyse complex datasets, identify promising drug… Continue reading Novo Nordisk taps OpenAI to boost AI in drug development

OpenAI’s massive $852 billion valuation is coming under scrutiny from some of its own investors as the company pivots its focus toward enterprise offerings, according to a report by the Financial Times published on Tuesday. The concerns emerge as the company pivots towards enterprise-focused offerings in an effort to counter rising competition. The shift in… Continue reading Why is OpenAI’s $852B valuation facing investor scrutiny?

Barclays has picked out IAG and Ryanair as its preferred names in Europe’s airline sector and argued that elevated fuel costs are doing more than squeezing margins. They are beginning to redraw the competitive map. At a moment when the world is facing oil volatility, supply disruption, and fare pressure, the broker’s call is effectively… Continue reading Barclays names European airline stocks you cannot afford to miss